Microbot Medical Inc., developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized academic medical center in Atlanta, has become the first hospital to adopt LIBERTY for patient care. Additionally, Microbot is collaborating with Emory to establish an Endovascular Robotics Program in interventional radiology to enhance the growing and evolving specialty field.

LIBERTY is the only FDA cleared, single-use, remotely operated robotic system for peripheral endovascular procedures, and it is designed for precise vascular navigation while aiming to reduce radiation exposure and physical strain. Just weeks ago, the Company commenced the limited market release of the system and plans for a full market release at the Society of Interventional Radiology (SIR) conference in April 2026, allowing the Company to showcase LIBERTY with the goal to deepen market adoption.
Emory University Hospital is a leading academic medical center recognized for its excellence in patient care, research, and innovation. With the hospital’s strengths in endovascular and oncology services, Microbot will support clinicians in delivering precise care for peripheral intervention procedures such as liver tumor embolization, prostate artery embolization and uterine fibroid embolization, among others.